Back to results
US 2014/0271462 A1Published application
Antigen binding constructs to cd8
AssigneeImaginab, Inc.
InventorsDavid T. Ho, Tove Olafsen, Giti Agahi, Christian P. Behrenbruch
Life of this patent
Estimating the term…
Abstract
Antigen binding constructs that bind to CD8, for example antibodies, including antibody fragments (such as scFv, minibodies, and cys-diabodies) that bind to CD8, are described herein. Methods of use are described herein.
Claims26
An antigen binding construct that comprises:
- a HCDR1 of a HCDR1 of SEQ ID NO:
- 3 or 6;
- a HCDR2 of HCDR1 of SEQ ID NO:
- 3 or 6;
- a HCDR3 of HCDR1 of SEQ ID NO:
- 3 or 6;
- a LCDR1 of LCDR1 of SEQ ID NO:
- 9;
- a LCDR2 of LCDR1 of SEQ ID NO:
- 9;
- and
- a LCDR3 of LCDR1 of SEQ ID NO:
- 9.
10 more elements
A humanized cys-diabody that binds to CD8, the humanized cys-diabody comprising a polypeptide that comprises:
- a single-chain variable fragment (scFv) comprising a variable heavy (VH) domain linked to a variable light (VL) domain;
- and
- a C-terminal cysteine.
A humanized minibody that binds to CD8, the humanized minibody comprising a polypeptide that comprises from N-terminus to C-terminus:
- a single-chain variable fragment (scFv) that binds to CD8, the scFv comprising a variable heavy (VH) domain linked to a variable light (VL) domain;
- a hinge-extension domain comprising a human IgG1 hinge region;
- and
- a human IgG CH3 sequence.
1 more element
Dependencies are inferred from the claim text.